HB2955 revises the Oklahoma Captive Insurance Company Act, which governs insurer structures used by affiliated businesses, associations, industrial insured groups, sponsors, and other specialized captive arrangements. The bill updates statutory definitions and licensing standards, including clarifying terms tied to participants, protected cells, sponsors, and public bodies, and it expands the Commissioner’s authority to regulate, approve, and monitor captive insurers and sponsored captive structures.
A major focus of the bill is protected cell captive insurance companies. It adds detailed rules for how protected cells are created, accounted for, converted, transferred, merged, and litigated. The bill requires separate accounting and recordkeeping for each protected cell, limits the use of cell assets to cell-specific liabilities, and establishes procedures for notice, participant consent, and Insurance Commissioner approval before major structural changes. It also provides that protected cells are not separate legal persons unless specifically structured as entity-protected cells, and it clarifies how claims, discovery, rehabilitation, and liquidation are handled when a sponsored captive insurer is involved.
The bill also changes financial and regulatory requirements for captive insurers. It modifies minimum capital and surplus thresholds for several captive types, allows certain irrevocable letters of credit from commissioner-approved financial institutions, shortens the response time for commissioner inquiries, and authorizes suspension, revocation, and civil penalties for noncompliance. It revises premium tax provisions, including how taxes are calculated and distributed, and it updates dormant captive company requirements by lowering the capital and annual fee thresholds and adjusting dormancy tax treatment.
In addition, HB2955 authorizes new operational flexibility for captives, including the use of foreign currency or foreign securities in approved business plans and the ability of public bodies to use public funds to capitalize a captive insurance company or provide guaranty capital for a mutual captive. It also repeals an existing statute governing conversion or merger, replacing it with new conversion, conveyance, and merger provisions for protected cells and related captive forms. The act is set to take effect November 1, 2026.
The overall sentiment appears favorable and largely technical rather than controversial. The bill passed the House Insurance Committee unanimously, cleared the House Commerce and Economic Development Oversight Committee with only one no vote, and passed House third reading by a wide margin. The Senate Business & Insurance Committee also reported it out unanimously. The broad support suggests the measure is viewed as a modernization and clarification of captive insurance law, though the detailed protected-cell rules, commissioner approval requirements, and tax/financial changes are the main areas where stakeholders could focus on compliance burden or regulatory discretion.
HB2955 amends multiple sections of Title 36 governing captive insurers, sponsored captive insurers, protected cells, dormant captives, premium taxation, and related regulatory procedures. It increases and clarifies the Insurance Commissioner’s oversight authority, imposes new accounting, notice, approval, and reporting requirements, and replaces the prior conversion/merger statute with a more detailed framework for protected cell conversions, transfers, and mergers. It also changes minimum capital and surplus requirements for several captive categories, revises premium tax distribution formulas, and authorizes public bodies to capitalize captive insurers.
The bill appears to have strong bipartisan and committee support, with unanimous or near-unanimous committee votes and a large House floor majority. The available record suggests the measure is generally viewed as a technical update to Oklahoma’s captive insurance framework rather than a highly partisan policy change. No committee transcript is available, but the vote pattern indicates broad acceptance of the bill’s regulatory clarifications and structural updates.
The main points of potential contention are the expanded regulatory authority given to the Insurance Commissioner, the new approval requirements for conversions, mergers, transfers, and participant contracts, and the detailed segregation rules for protected cell assets and liabilities. Insurers and sponsors may view the new reporting, notice, and accounting obligations as burdensome, while regulators and policyholder advocates may support them as necessary safeguards. The bill also adjusts capital thresholds and tax distributions, which could draw attention from captive insurers, public finance stakeholders, and entities considering use of protected cells or public-body capitalization.